Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

Abstract

Presently, no data on the molecular basis of hereditary protein C (PC) deficiency in Spain is available. We analyzed the PC gene (PROC) in 109 patients with symptomatic PC deficiency and in 342 relatives by sequencing the 9 PROC exons and their flanking intron regions. In 93 probands, we found 58 different mutations (26 novel). Thirty-seven consisted of a nucleotide change, mainly missense mutations, 1 was a 6-nucleotide insertion causing the duplication of 2 amino acids, and 4 were deletions of 1, 3, 4, and 16 nucleotides. Nine mutations caused type II deficiencies, with the presence of normal antigen levels but reduced anticoagulant activity. Using a PC level of 70% as lowest normal limit, we found no mutations in 16 probands and 25 relatives with PC levels ≤ 70%. On the contrary, 4 probands and 12 relatives with PC levels > 70% carried the mutation identified in the proband. The spectrum of recurrent mutations in Spain is different from that found in the Netherlands, where the most frequent mutations were p.Gln174* and p.Arg272Cys, and is more similar to that found in France, where the most frequent were p.Arg220Gln and p.Pro210Leu. In our study, p.Val339Met (9 families), p.Tyr166Cys (7), p.Arg220Gln (6), and p.Glu58Lys (5) were the most prevalent. This study confirms the considerable heterogeneity of the genetic abnormality in PC deficiencies, and allowed genetic counseling to those individuals whose PC levels were close to the lower limit of the normal reference range.

Keywords

protein C deficiency - gene mutations - venous thromboembolism - family study

• References

• 1 Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci U S A 1996; 93 (19) 10212-10216
• 2 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68 (05) 1370-1373
• 3 Estellés A, García-Plaza I, Dasí A. , et al. Severe inherited “homozygous” protein C deficiency in a newborn infant. Thromb Haemost 1984; 52 (01) 53-56
• 4 Sills RH, Marlar RA, Montgomery RR, Deshpande GN, Humbert JR. Severe homozygous protein C deficiency. J Pediatr 1984; 105 (03) 409-413
• 5 España F, Vayá A, Mira Y. , et al. Low level of circulating activated protein C is a risk factor for venous thromboembolism. Thromb Haemost 2001; 86 (06) 1368-1373
• 6 Rovida E, Merati G, D'Ursi P. , et al. Identification and computationally-based structural interpretation of naturally occurring variants of human protein C. Hum Mutat 2007; 28 (04) 345-355
• 7 Plutzky J, Hoskins JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci U S A 1986; 83 (03) 546-550
• 8 Martos L, Bonanad S, Ramón LA. , et al. A simplified assay for the quantification of circulating activated protein C. Clin Chim Acta 2016; 459: 101-104
• 9 Miletich J, Sherman L, Broze Jr G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317 (16) 991-996
• 10 Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 1988; 59 (01) 18-22
• 11 Bertina RM. Protein C deficiency and venous thrombosis--the search for the second genetic defect. Thromb Haemost 2000; 83 (03) 360-361
• 12 Rajpurkar M, Biss T, Amankwah EK. , et al. Pulmonary embolism and in situ pulmonary artery thrombosis in paediatrics. A systematic review. Thromb Haemost 2017; 117 (06) 1199-1207
• 13 Medina P, Navarro S, Estellés A. , et al. Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk. Thromb Haemost 2004; 91 (05) 905-911
• 14 Navarro S, Bonet E, Estellés A. , et al. The endothelial cell protein C receptor: its role in thrombosis. Thromb Res 2011; 128 (05) 410-416
• 15 Martos L, Ramón LA, Oto J. , et al. α₂-macroglobulin is a significant in vivo inhibitor of activated protein C and low APC:α₂M levels are associated with venous thromboembolism. Thromb Haemost 2018; 118 (04) 630-638
• 16 Tsay W, Lee YM, Lee SC, Shen MC, Chen PJ. Characterization of human protein C gene promoter: insights from natural human mutants. DNA Cell Biol 1996; 15 (11) 907-919
• 17 Alhenc-Gelas M, Gandrille S, Aubry M-L, Aiach M. Thirty-three novel mutations in the protein C gene. French INSERM network on molecular abnormalities responsible for protein C and protein S. Thromb Haemost 2000; 83 (01) 86-92
• 18 España F, Estellés A, Aznar J, Gilabert J. Assay of protein C in human plasma: comparison of amidolytic, coagulation, and immunochemical assays. Thromb Res 1986; 44 (06) 771-782
• 19 den Dunnen JT, Dalgleish R, Maglott DR. , et al. HGVS Recommendations for the Description of Sequence Variants: 2016 update. Hum Mutat 2016; 37 (06) 564-569
• 20 Gandrille S, Aiach M. Identification of mutations in 90 of 121 consecutive symptomatic French patients with a type I protein C deficiency. The French INSERM Network on Molecular Abnormalities Responsible for Protein C and Protein S deficiencies. Blood 1995; 86 (07) 2598-2605
• 21 Reitsma PH, Poort SR, Allaart CF, Briët E, Bertina RM. The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects. Blood 1991; 78 (04) 890-894
• 22 Dodojacek R, Höfler G, Leschnik B, Muntean W. A novel type of mutation at the propeptide cleavage site (AlA+1Thr) causing symptomatic protein C type II deficiency. Thromb Res 2000; 100 (01) 109-113
• 23 Conard J, Horellou MH, van Dreden P. , et al. Homozygous protein C deficiency with late onset and recurrent coumarin-induced skin necrosis. Lancet 1992; 339 (8795): 743-744
• 24 Grundy CB, Schulman S, Tengborn L, Kakkar VV, Cooper DN. Two different missense mutations at Arg 178 of the protein C (PROC) gene causing recurrent venous thrombosis. Hum Genet 1992; 89 (06) 685-686
• 25 Gandrille S, Vidaud M, Aiach M. , et al. Six previously undescribed mutations in 9 families with protein C quantitative deficiency. Thromb Haemost 1991; 65: 646
• 26 Soria JM, Fontcuberta J, Borrell M, Estivill X, Sala N. Protein C deficiency: identification of a novel two-base pair insertion and two point mutations in exon 7 of the protein C gene in Spanish families. Hum Mutat 1992; 1 (05) 428-431
• 27 Zhang L, Jhingan A, Castellino FJ. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 1992; 80 (04) 942-952
• 28 Ingerslev J, Herlin T, Sørensen B, Clausen N, Chu KC, High KA. Severe factor X deficiency in a pair of siblings: clinical presentation, phenotypic and genotypic features, prenatal diagnosis and treatment. Haemophilia 2007; 13 (03) 334-336
• 29 Greengard JS, Fisher CL, Villoutreix B, Griffin JH. Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: patterns revealed by three-dimensional molecular modelling of mutations of the protease domain. Proteins 1994; 18 (04) 367-380
• 30 Preston RJ, Villegas-Mendez A, Sun YH. , et al. Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation. FEBS J 2005; 272 (01) 97-108
• 31 Caspers M, Pavlova A, Driesen J. , et al. Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort. Thromb Haemost 2012; 108 (02) 247-257
• 32 Sala N, Soria JM, Borrell M, Navarro G, Fontcuberta J, Estivill X. Estudio de la mutación causante del déficit cualitativo de PC en tres familias. Sangre (Barc) 1993; 38: 20
• 33 Aiach M, Gandrille S. Molecular basis for protein C hereditary deficiency. Haemostasis 1996; 26 (Suppl. 04) 9-19
• 34 Limperger V, Klostermeier UC, Kenet G. , et al. Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study. Br J Haematol 2014; 167 (03) 385-393
• 35 Brüwer G, Limperger V, Kenet G. , et al. Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study. Blood Cells Mol Dis 2016; 62: 24-31